Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02649075 · ClinicalTrials.gov registry record · NA
To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease
A NA study, sponsored by Entera Health.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02649075: Clinical Trial NA study, sponsored by Entera Health.
NCT02649075 is a NA study that was terminated before completion, run by Entera Health. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02649075, a NA study, was terminated before completion, sponsored by Entera Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the nutritional therapy with SBI (a medical food) as compared to placebo in the clinical dietary management of mild to moderate Crohn's disease.
Interventions
- OTHER Placebo
- OTHER Serum-derived Bovine Immunoglobulin / Protein Isolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-08 |
| Phase | NA |
Why NCT02649075 stopped before completion
NCT02649075 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02649075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02649075 about?
NCT02649075 is a clinical study titled "To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease". The objective of this study is to evaluate the nutritional therapy with SBI (a medical food) as compared to placebo in the clinical dietary management of mild to moderate Crohn's disease.
What is the current status of trial NCT02649075?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2016-02. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02649075?
The interventions under investigation include: Placebo (OTHER), Serum-derived Bovine Immunoglobulin / Protein Isolate (OTHER).
Who is sponsoring clinical trial NCT02649075?
This trial is sponsored by Entera Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02649075's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia